Related Experiment Video
Updated: Feb 26, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
The morphogen behind primary congenital glaucoma and the dream of targeting
Kyrillus Samaan Shohdy1, Wegdan Aly Rashad, Mohamed Khalid Fargoun
1Faculty of Medicine, Cairo University, Cairo University Hospitals, Cairo, Egypt; kerosam501@gmail.com.
Insights
Primary congenital glaucoma (PCG) involves genetic mutations, morphogen issues, and trabecular meshwork changes. Understanding these factors is key to addressing this infant eye disease.
Area of Science:
- Ophthalmology
- Genetics
- Developmental Biology
Background:
- Glaucoma is a complex eye condition with multiple causes.
- Primary congenital glaucoma (PCG) is a severe infantile subtype.
- PCG results from a sequential interaction of genetic, morphogenic, and structural factors.
Purpose of the Study:
- To detail the three interacting levels contributing to PCG.
- To explore the morphological basis of primary congenital glaucoma.
- To identify knowledge gaps regarding morphogen function and CYP1B1's role.
Main Methods:
- Review of genetic mutations, focusing on CYP1B1.
- Analysis of morphogen absence or dysregulation.
- Examination of trabecular meshwork pathological changes in patterning and remodeling.
Main Results:
- Identified genetic mutations, primarily in CYP1B1, as a key factor.
- Highlighted the role of morphogen dysregulation in PCG development.
- Detailed trabecular meshwork abnormalities in affected infants.
Conclusions:
- PCG pathogenesis is multifactorial, involving genetic, morphogenic, and structural elements.
- Further research is needed on morphogen function and the precise role of CYP1B1.
- Understanding these interactions is crucial for PCG diagnosis and treatment.
Abstract:
Glaucoma is a clinical entity with multifactorial etiology, a severe subtype occurs in infancy called primary congenital glaucoma (PCG). Three distinct levels interact sequentially to produce PCG: (i) genetic mutations mainly affecting the CYP1B1 gene, (ii) absence or dysregulation of a morphogen, and (iii) trabecular meshwork pathological changes either in patterning or remodeling. We will discuss these three levels in detail towards further understanding of the morphological basis of the disease, focusing on the missing points, for instance the exact nature and function of the morphogen along with the putative role of CYP1B1 gene.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Angle Closure Glaucoma: Treatment

